BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3262809)

  • 1. Erythromycin, miocamycin and clindamycin towards adhesivity and phagocytosis of gram-positive bacteria.
    Mascellino MT; Catania S; De Vito ML; De Bac C
    Microbiologica; 1988 Jul; 11(3):231-41. PubMed ID: 3262809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phagocytosis and killing of A-protein positive Staphylococcus aureus in the presence of low doses of antibiotics.
    Mascellino MT; De Vito ML; Maclean Feeney E; Iegri F; Catania S
    Drugs Exp Clin Res; 1989; 15(2):63-9. PubMed ID: 2737081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of miocamycin and erythromycin on the activity of human neutrophils against Staphylococcus aureus].
    García I; Pascual A; Guzmán MC; Perea EJ
    Enferm Infecc Microbiol Clin; 1991 Oct; 9(8):459-63. PubMed ID: 1666841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In vitro antibacterial activity of a new macrolide: miokamycin. Comparison with erythromycin and josamycin].
    Soussy CJ; Leclercq R; Duval J
    Pathol Biol (Paris); 1988 May; 36(5):370-6. PubMed ID: 3043331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of sub-inhibitory concentrations of antibiotics on adhesion of Campylobacter jejuni in vitro.
    Cinco M; Banfi E; Crevatin D; Ruaro E
    Boll Ist Sieroter Milan; 1987; 66(2):106-9. PubMed ID: 3663336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clindamycin and its action on the susceptibility of pathogenic bacteria to phagocytosis.
    Gemmell CG
    Scand J Infect Dis Suppl; 1984; 43():17-23. PubMed ID: 6398907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vitro activity of miocamycin compared with four other macrolides and with pristinamycin against Branhamella catarrhalis].
    Suermondt G; Denamur E; Fleuret A; Laurans G; Orfila J
    Pathol Biol (Paris); 1989 May; 37(5):386-9. PubMed ID: 2506513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [In vitro antibacterial activity of a new macrolide, miokamycin. Results of a multicenter study].
    Soussy CJ; Thabaut A; Bismuth R; Morel C; Berthelot G; Chanal M; Derlot E
    Pathol Biol (Paris); 1989 May; 37(5):358-63. PubMed ID: 2674868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of flurithromycin, a novel macrolide antibiotic.
    Gialdroni Grassi G; Alesina R; Bersani C; Ferrara A; Fietta A; Peona V
    Chemioterapia; 1986 Jun; 5(3):177-84. PubMed ID: 3487389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro comparative study of RU 28965 against organisms from oral and vaginal flora.
    Romeo MA; Lo Bue AM; Chisari G; Gismondo MR; Nicoletti G
    G Batteriol Virol Immunol; 1986; 79(1-6):16-24. PubMed ID: 3500081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postantibiotic effect of roxithromycin, erythromycin, and clindamycin against selected gram-positive bacteria and Haemophilus influenzae.
    Kuenzi B; Segessenmann C; Gerber AU
    J Antimicrob Chemother; 1987 Nov; 20 Suppl B():39-46. PubMed ID: 3501426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-mycoplasmal activity of a new macrolide: miocamycin.
    Furneri PM; Tempera G; Bisignano G; Cottarelli FV; Nicoletti G
    Chemioterapia; 1987 Oct; 6(5):341-5. PubMed ID: 3501335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of bacterial adhesion by sub-inhibitory concentrations: brodimoprim vs trimethoprim.
    Braga PC; Piatti G; Limoli A; Santoro M; Gazzola T
    J Chemother; 1993 Dec; 5(6):447-52. PubMed ID: 8195836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of clindamycin resistance in erythromycin-resistant, clindamycin susceptible and methicillin-resistant clinical Staphylococcal isolates.
    Kader AA; Kumar A; Krishna A
    Saudi Med J; 2005 Dec; 26(12):1914-7. PubMed ID: 16380772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of subinhibitory concentrations of josamycin on the expression of M protein by group A streptococci.
    Lam C; Basalka E
    Eur J Clin Microbiol; 1985 Jun; 4(3):279-81. PubMed ID: 3894016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility in vitro of gram-positive aerobe and anaerobe bacteria to ofloxacin.
    Debbia E; Mannelli S; Gianrossi G; Schito GC
    Drugs Exp Clin Res; 1987; 13(4):213-7. PubMed ID: 3304918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-vitro postantibiotic effects of miocamycin and erythromycin on gram-positive cocci.
    Varotto F; Garlaschi ML; Garlaschi MC; Falchi M; Scaglione F; Cattaneo G; De Luca M; Fraschini F
    J Chemother; 1990 Dec; 2(6):355-61. PubMed ID: 2093106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The rate of inducible clindamycin resistance and susceptibilities to other antimicrobial agents in staphylococci].
    Oğuz VA; Yapar N; Sezak N; Cavuş SA; Kurutepe S; Peksel H; Cakir N; Yüce A
    Mikrobiyol Bul; 2009 Jan; 43(1):37-44. PubMed ID: 19334378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sub-MIC concentrations of rokitamycin inhibit S. aureus' adhesiveness to human epithelial cells].
    Braga PC; Piatti G; Allegra L
    G Ital Chemioter; 1991; 38(1-3):117-8. PubMed ID: 1365561
    [No Abstract]   [Full Text] [Related]  

  • 20. Activities of human alveolar macrophages (HAMs). Note 1: Observations on phagocytosis and bacterial killing in the presence of miocamycin.
    Capelli A; Capelli O; Azzolini L; Richeldi L; Prandi E; Velluti G
    Chemioterapia; 1988 Apr; 7(2):89-95. PubMed ID: 3260827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.